Business / Finance

RSS

Magellan reports net revenue of $692.8 million for first quarter 2011

Magellan Health Services, Inc. today reported financial results for the first quarter of 2011, as summarized below, and increased guidance for the full year.

30 Apr 2011

Noveko closes private placement for $595,104

Noveko International Inc. announces a first closing of $595,104 of its private placement. Additional closings are expected until May 23, 2011.

30 Apr 2011

HMS first quarter revenue increases 27% to $82.5 million

HMS Holdings Corp. Reports Record First Quarter 2011 Results

30 Apr 2011

Oncothyreon prices underwritten public offering of common stock

Oncothyreon Inc. today announced that it has priced an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $4.00 per share for gross proceeds of $40.0 million. The net proceeds from the sale of the shares, after deducting the underwriters' discounts and other estimated offering expenses payable by Oncothyreon, will be approximately $37.4 million.

29 Apr 2011

LifePoint Hospitals first quarter revenues increase 13.0% to $888.6 million

LifePoint Hospitals, Inc. today announced results for the first quarter ended March 31, 2011.

29 Apr 2011

Amerigroup first quarter total revenues increase 12.3% to $1.54 billion

Amerigroup Corporation today announced that net income for the first quarter of 2011 was $70.5 million, or $1.37 per diluted share, versus net income of $42.2 million, or $0.82 per diluted share, for the first quarter of 2010. Total revenues for the first quarter of 2011 increased 12.3% to $1.54 billion compared with $1.37 billion in the first quarter of 2010. Sequentially, total revenues increased 2.5% from the fourth quarter of 2010.

29 Apr 2011

China Pharmaceuticals net sales increase 28% to $34,184,906

China Pharmaceuticals, Inc., one of China's leading manufacturers and distributors of prescription and over-the-counter pharmaceuticals today announced its financial results for fiscal year ended December 31, 2010.

29 Apr 2011

Iroko Pharmaceuticals announces acquisition of iCeutica

Iroko Pharmaceuticals, LLC today announces that it has acquired iCeutica, Inc. to further strengthen Iroko's position as the leading developer of novel, low-dose non-steroidal anti-inflammatory drugs.

29 Apr 2011

HealthSpring reports net income of $44.2 million for first quarter 2011

HealthSpring, Inc. today announced its results for the first quarter ended March 31, 2011, which include the results of Bravo Health, Inc., acquired by the Company in November 2010.

29 Apr 2011

ZOLL Medical second quarter revenues increase 14% to $122.5 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the second quarter of fiscal 2011 increased 14% to $122.5 million, compared to revenues in the second quarter of last year of $107.1 million.

28 Apr 2011

Cerus first quarter total revenue is $6.6 million for 2011

Cerus Corporation today announced financial results for the first quarter ended March 31, 2011.

28 Apr 2011

Informed Medical Decisions announces acquisition of AccessDNA

Informed Medical Decisions, Inc. announced today it is acquiring AccessDNA, Inc., owner of Inherited Health, a leading online resource for individuals and families interested in understanding family history and hereditary disease risks.

28 Apr 2011

GE Healthcare reaches agreement to acquire Applied Precision

GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire Applied Precision, Inc., a supplier of innovative cellular imaging technologies for the fast-growing cell biology and biomedical research sectors.

28 Apr 2011

Adolor first quarter net loss decreases to $7.3 million

Adolor Corporation today reported net sales of ENTEREG® (alvimopan) were $7.5 million for the three months ended March 31, 2011, a 42% increase compared to net sales of $5.3 million for the three months ended March 31, 2010.

28 Apr 2011

Nautic Partners announces acquisition of Omnicare Clinical Research

Nautic Partners LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has acquired Omnicare Clinical Research from Omnicare, Inc. Headquartered in King of Prussia, PA, Omnicare CR is a full-service, global clinical research organization.

28 Apr 2011

Merck, Inspire announce expiration of HSR waiting period for cash tender offer

Merck, known as MSD outside the United States and Canada, and Inspire Pharmaceuticals, Inc. today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR") has expired in connection with the previously announced cash tender offer made by Monarch Transaction Corp., a wholly owned subsidiary of Merck, to purchase all of the outstanding shares of common stock of Inspire.

28 Apr 2011